Curis, Inc. (CRIS)
NASDAQ: CRIS · Real-Time Price · USD
3.080
+0.010 (0.33%)
At close: Dec 20, 2024, 4:00 PM
3.230
+0.150 (4.87%)
After-hours: Dec 20, 2024, 7:51 PM EST
Curis Revenue
Curis had revenue of $2.93M in the quarter ending September 30, 2024, with 3.46% growth. This brings the company's revenue in the last twelve months to $10.26M, up 0.44% year-over-year. In the year 2023, Curis had annual revenue of $10.02M, down -1.37%.
Revenue (ttm)
$10.26M
Revenue Growth
+0.44%
P/S Ratio
1.75
Revenue / Employee
$209,367
Employees
49
Market Cap
26.08M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 10.02M | -139.00K | -1.37% |
Dec 31, 2022 | 10.16M | -487.00K | -4.57% |
Dec 31, 2021 | 10.65M | -186.00K | -1.72% |
Dec 31, 2020 | 10.84M | 831.00K | 8.31% |
Dec 31, 2019 | 10.00M | -424.00K | -4.07% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
HOOKIPA Pharma | 50.00M |
DURECT | 8.59M |
LAVA Therapeutics | 7.35M |
Daré Bioscience | 1.88M |
Adagio Medical Holdings | 543.00K |
Gelteq | 95.62K |
CRIS News
- 12 days ago - Curis Announces Additional Data from TakeAim Leukemia Study - PRNewsWire
- 5 weeks ago - Curis, Inc. (CRIS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Curis Provides Third Quarter 2024 Business Update - PRNewsWire
- 6 weeks ago - Curis to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on November 14, 2024 - PRNewsWire
- 7 weeks ago - Curis Announces $12.1 Million Registered Direct and Concurrent Private Placement - PRNewsWire
- 3 months ago - Curis Announces the 3rd Annual Symposium on IRAK4 in Cancer - PRNewsWire
- 3 months ago - Curis to Participate at the Upcoming 2024 Cantor Fitzgerald Global Healthcare Conference - PRNewsWire
- 3 months ago - Curis to Present at Upcoming Healthcare Conferences in September - PRNewsWire